Middle Meningeal Artery Embolization (MMAE) Outcomes for Chronic Subdural Hematoma (cSDH)

Summary

This multi-center retrospective cohort study aims to investigate the real-world outcomes of chronic subdural hematoma treated with MMAE, including clinical effectiveness, recurrence rates, and safety profile.

Conditions

• Chronic Subdural Hematoma

Sponsors & Collaborators

• Geisinger Clinic

  collaborator OTHER

• Heidelberg University

  collaborator OTHER

• Henri Mondor University Hospital

  collaborator OTHER

• Ospedale Policlinico San Martino

  collaborator OTHER

• Ospedale San Raffaele

  collaborator OTHER

• Lehigh Valley Hospital

  collaborator OTHER

• Mayo Clinic

  collaborator OTHER

• Medical University of South Carolina

  collaborator OTHER

• New York University

  collaborator OTHER

• Oregon Health and Science University

  collaborator OTHER

• Sisters of Mercy University Hospital

  collaborator OTHER

• Unity Health Toronto

  collaborator OTHER

• Sutter Health

  collaborator OTHER

• University of Iowa

  collaborator OTHER

• Thomas Jefferson University

  collaborator OTHER

• University Health Network, Toronto

  collaborator OTHER

• University Hospital, Bordeaux

  collaborator OTHER

• University of Alabama at Birmingham

  collaborator OTHER

• University of South Florida

  collaborator OTHER

• University of Washington

  collaborator OTHER

• Cornell University

  collaborator OTHER

• Westchester Medical Center

  collaborator OTHER

• Montefiore Medical Center

  lead OTHER

Principal Investigators

• David Altschul, MD · Montefiore Medical Center

Eligibility

Min Age

18 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2023-12-05

Primary Completion

2026-08-31

Completion

2026-08-31

Countries

• United States
• Australia
• Canada

Study Locations